The optimal timing of hemoperfusion component in combined hemodialysis-hemoperfusion treatment for uremic toxins removal.

Li, Jiangtao; Li, Daming; Xu, Yan; Wang, Aili; Xu, Chen; Yu, Chen

Li, Jiangtao; Li, Daming; Xu, Yan; Wang, Aili; Xu, Chen; Yu, Chen.

Affiliation

Li J; Department of Nephrology, Tongji Hospital, Tongji University , Shanghai , China.

Ren Fail ; 37(1): 103-7, 2015 Feb.

Article in En | MEDLINE | ID: mdl-25421427

Subject(s)

Hemoperfusion; Kidney Failure, Chronic; Renal Dialysis; Uremia; Adult; Aged; Comparative Effectiveness Research; Creatinine/blood; Female; Hemoperfusion/adverse effects; Hemoperfusion/methods; Humans; Interleukin-1/blood; Interleukin-6/blood; Kidney Failure, Chronic/blood; Kidney Failure, Chronic/complications; Kidney Failure, Chronic/therapy; Male; Middle Aged; Monitoring, Physiologic/methods; Renal Dialysis/adverse effects; Renal Dialysis/methods; Time-to-Treatment; Treatment Outcome; Tumor Necrosis Factor-alpha/blood; Uremia/blood; Uremia/etiology; Uremia/therapy

Key words

Chronic hemodialysis; cytokines; hemoperfusion; middle-sized molecules; small water-soluble solutes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uremia / Renal Dialysis / Hemoperfusion / Kidney Failure, Chronic Type of study: Clinical_trials / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ren Fail Journal subject: NEFROLOGIA Year: 2015 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google